Placebo (treatment C)

DRUG3 trials

Sponsors

Dr. Reddy's Laboratories Limited, Mallinckrodt, H. Lundbeck A/S

Conditions

HealthyMigrainePainParkinson Disease

Phase 1

Study Investigating Effects of Foliglurax in Patients With Parkinson's Disease (PD) and Healthy Subjects

TerminatedNCT04322227

H. Lundbeck A/SHealthy, Parkinson Disease

Start: 2020-01-23End: 2020-05-30Updated: 2020-07-07

Phase 2

Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches

CompletedNCT02472418

Dr. Reddy's Laboratories LimitedMigraine

Start: 2015-06-05End: 2016-05-05Updated: 2018-05-22

Phase 4

Reduction in Pain Intensity Following IV or Oral Pain-relieving Products

CompletedNCT02678416

MallinckrodtPain

Start: 2015-12-07End: 2016-06-13Updated: 2020-02-05

Related Papers

Efficacy and safety of DFN-15, an oral liquid formulation of celecoxib, in adults with migraine: a multicenter, randomized, placebo-controlled, double-blind, crossover study

Neuropsychiatric Disease and Treatment2017-11-017 citations